Polycythemia (Erythrocytosis)

01/01/2007 - "Sustained-release erythropoietin ameliorates cardiac function in infarcted rat-heart without inducing polycythemia."
10/01/2011 - "A therapeutic candidate, erythropoietin (EPO), has shown promise in many models of these diseases; however, it also causes polycythemia, a potentially lethal side effect. "
01/23/1993 - "Cultures of hematopoietic precursor cells can be helpful in differentiating between primary polycythemia (polycythaemia vera, PV) and reactive secondary polycythemia: in PV erythroid precursors form hemoglobinized colonies in the absence of added erythropoietin (epo) (= endogenous erythroid colonies), whereas in normals and in patients with secondary polycythemia, formation of erythroid colonies is dependent on added epo. "
01/01/2014 - "Studies to investigate the cause of erythrocytosis were started and elevated erythropoietin levels were found. "
05/01/2012 - "If causes of secondary erythrocytosis are not evident and serum erythropoietin level is low-normal, I study JAK2 mutations. "

06/01/2007 - "Remission of posttransplant erythrocytosis can be seen in all patients; however, some patients may require treatment with phlebotomy or angiotensin-converting enzyme inhibitors. "
03/16/2004 - "Angiotensin-converting enzyme inhibitors for secondary erythrocytosis."
07/15/1999 - "Angiotensin-converting enzyme inhibitors (ACEI) have become the treatment of choice for posttransplantation erythrocytosis (PTE). "
07/01/1998 - "Of the nine patients eligible for follow-up, all four with spontaneous growth of BFU-E had transient erythrocytosis and four of the five patients with no spontaneous growth or spontaneous growth of CFU-E only had persistent erythrocytosis requiring treatment with ACE inhibitors. "
04/01/2000 - "Our results suggest that angiotensin-converting enzyme inhibitors are a safe and effective long-term therapy of postrenal transplant erythrocytosis. "

02/01/1993 - "Enalapril: safe and effective therapy for posttransplant erythrocytosis."
04/15/1994 - "After 3 months of therapy, enalapril was withdrawn and patients were observed in order to differentiate spontaneous remission of erythrocytosis from effects of enalapril therapy. "
04/15/1994 - "Our study proves that enalapril can be safely and effectively used to treat posttransplant erythrocytosis. "
12/01/1999 - "Management of posttransplant erythrocytosis with enalapril."
07/01/1995 - "Effect of enalapril on erythrocytosis in hypertensive patients with renal disease."

11/01/2005 - "However, because other studies have shown that polycythemia may not reduce oxygen delivery, an alternative hypothesis is that cardiac output falls in response to a rising oxygen content, thereby maintaining oxygen delivery constant. "
11/01/2005 - "Previous studies have concluded that polycythemia decreases oxygen delivery primarily because of a large fall in cardiac output associated with a rise in systemic vascular resistance that has been attributed to increased blood viscosity. "
01/01/2005 - "Functional studies carried out on diluted whole hemolysates and isolated Hb components from the proband demonstrated an increased oxygen affinity, consistent with the existence of mild erythrocytosis."
01/01/1949 - "BLOOD OXYGEN STUDIES IN PATIENTS WITH POLYCYTHEMIA AND IN NORMAL SUBJECTS."
10/01/2015 - "Secondary erythrocytosis is an associated physiological response intended to increase circulating red blood cells and oxygen carrying capacity. "

11/01/1996 - "The effect of theophylline on erythrocytosis without elevated EPO levels does make a unifying hypothesis even more difficult. "
07/01/1993 - "Use of theophylline to control hematocrit in respiratory polycythemia."
03/01/1992 - "A 3-month course of theophylline therapy did not influence the erythrocytosis significantly. "
01/01/1995 - "Theophylline modulates erythrocytosis after renal transplantation."
12/06/1990 - "Theophylline for erythrocytosis after renal transplantation."

06/01/1998 - "Our findings suggest that losartan can be effective and safe in the treatment of posttransplant erythrocytosis."
01/01/2004 - "Efficacy of losartan in the treatment of erythrocytosis in a young adult with CRF."
02/01/2001 - "The effect of losartan on posttransplant erythrocytosis."
06/01/1998 - "We report three patients in which the use of losartan controlled posttransplant erythrocytosis. "
06/01/1998 - "Effects of losartan on the treatment of posttransplant erythrocytosis."

11/01/1997 - "These data showed that lisinopril is a valid therapy for the treatment of posttransplanted patients affected by erythrocytosis and, moreover, has the benefit of antihypertensive action. "
11/01/1997 - "The proposal of this study is to compare the efficacy of lisinopril and theophylline, alone or in association, on erythrocytosis in renal-transplanted patients. "
09/01/2002 - "Twenty-two patients with post kidney transplantation erythrocytosis were treated using ACE-inhibitors (lisinopril) at a dose of 2-5-5 mg/day for a mean period of 15 months. "
06/01/2002 - "Twenty-two patients with post kidney transplantation erythrocytosis were treated using ACE-inhibitors (lisinopril) at a dose of 2-5-5 mg/day for a mean period of 15 months. "
11/01/1997 - "[Treatment of post-transplant erythrocytosis: comparison of lisinopril and theophylline]."

12/01/2002 - "Postrenal transplant erythrocytosis: risk factors and effectiveness of angiotensin receptor antagonists."
08/01/1996 - "Effects of angiotensin-receptor antagonists on erythrocytosis after renal transplantation."
01/01/2002 - "GUIDELINE: In the case of erythrocytosis, the first-line treatment should be administration of ACE inhibitors or angiotensin II receptor antagonists."
01/01/2013 - "Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, currently being used in posttransplant erythrocytosis, might also be considered."
02/01/2000 - "[Erythrocytosis post kidney transplantation and its pharmacological treatment: angiotensin converting enzyme inhibitors or angiotensin receptor blockers in a case]."

06/01/2005 - "For this reason, a clinicopathological study was performed on 334 patients presenting with a sustained borderline to marked erythrocytosis (hemoglobin >17 g/dl in men and >15 g/dl in women). "
08/01/1987 - "These data, in conjunction with earlier studies of ethnic Tibetans living at 3,400 m, demonstrate a pattern of increasing hemoglobin concentration (erythrocytosis) at increasing altitude of residence in the Himalayas and Tibet. "
06/01/1985 - "Results are reported of studies of the hemoglobin from one member of a Canadian family with a mild erythrocytosis. "
11/01/1980 - "To study the isolated effects of decreased hemoglobin concentration without volume loss, eight patients with the diagnosis of polycythemia were studied following acute phlebotomy and simultaneous volume replacement. "
01/01/2014 - "She had severe polycythemia: hemoglobin (Hb), 19.9 g/dL; red blood cell count (RBC), 6.65 × 10(6)/mm(3); hematocrit, (Hct) 59.1%. "

04/16/2015 - "Meta-analyses of clinical trials of TRT as of 2010 have identified three major adverse events resulting from TRT: polycythemia, an increase in prostate-related events, and a slight reduction in serum high-density lipoprotein cholesterol. "
01/01/2006 - "Not only polycythemia and low high-density lipoprotein cholesterol level but also high leukocyte count, hearing loss, positive urinary occult blood, and high triglyceride level are smoking-related abnormal findings. "
03/01/2012 - "Although aromatase inhibitors appear effective in increasing adult height of boys with short stature and/or pubertal delay, safety concerns, including vertebral deformities, a decrease in serum HDL cholesterol levels and increase of erythrocytosis, are reasons for caution."
01/01/2006 - "The present study showed that increased age, body mass index, red blood cell count, white blood cell count, total cholesterol, low-density lipoprotein cholesterol, and triglyceride and decreased high-density lipoprotein cholesterol were associated with impaired blood rheology measured by microchannel method in healthy subjects, suggesting that aging, obesity, erythrocytosis, leukocytosis, and dyslipidemia may be related to hemorheological disorders. "

12/01/1995 - "We performed a randomized double-blind placebo-controlled study in 25 patients with post-transplant erythrocytosis. "
07/01/1982 - "A matched-pair control study of postrenal transplant polycythemia."
02/01/2015 - "Post-renal transplant erythrocytosis: a case report."
09/01/2014 - "Post-kidney transplant erythrocytosis (PTE) is one of the hematological complications in the renal transplant patients. "
09/01/2014 - "Angiogenic activity in the sera of patients with post-kidney transplant erythrocytosis."

11/01/2007 - "A 46-year-old man suspected of spurious polycythemia received nephrectomy. "
06/01/2006 - "We report a case of a secondary polycythemia caused by ureteropelvic junction obstruction that was successfully treated by laparoscopic nephrectomy."
06/01/2006 - "Secondary polycythemia caused by ureteropelvic junction obstruction successfully treated by laparoscopic nephrectomy."
01/01/2006 - "Erythrocytosis subsided after partial nephrectomy. "
06/01/1992 - "The polycythemia remitted following nephrectomy. "

09/29/1997 - "In this study factors possibly contributing to the development of erythrocytosis after renal transplantation (PTE) were analyzed. "
08/01/1983 - "Studies in polycythemia after kidney transplantation."
09/01/2010 - "Posttransplant erythrocytosis (PTE) is defined as a persistently elevated hematocrit to a level greater than 51% after renal transplantation. "
04/01/2010 - "Elevated incidence of posttransplant erythrocytosis after simultaneous pancreas kidney transplantation."
01/01/2010 - "[The erythrocytosis after renal transplantation: a retrospective study about 11 recipients ]."

03/01/2015 - "We retrospectively evaluated 99 consecutive patients undergoing therapeutic phlebotomy for either transfusional IO (TIO, n = 88; 76% had undergone hematopoietic transplantation) or nontransfusional indications (hyperferritinemia or erythrocytosis; n = 11). "
02/01/2014 - "Posttransplant erythrocytosis affected 9 renal transplant recipients (7.5%) with a mean (±SD) hematocrit of 41.3%±6.7%. "
06/01/2007 - "Of 1655 renal transplant recipients, 159 patients (9.6%; 154 men, 5 women; mean age, 42 +/- 9 years) developed posttransplant erythrocytosis. "
06/01/2007 - "Posttransplant erythrocytosis in renal transplant recipients at Jeddah Kidney Center, Kingdom of Saudi Arabia."
08/15/2001 - "Twenty-seven (24 male and 3 female, mean age 34+/-8 years) renal transplant recipients with erythrocytosis were treated either with E (15 patients) (10 mg/day) or L (12 patients) (50 mg/day) for 8 weeks. "

07/01/2008 - "Myomatous erythrocytosis syndrome is defined by the combination of erythrocytosis, myomatous uterus and persistent restoration of normal haematological values after hysterectomy. "
08/16/2006 - "The characteristics of this syndrome are raised haemoglobin and haematocrit values, erythrocytosis at normal plasma volumes and the fact that these values are promptly and permanently corrected by myomectomy or hysterectomy. "
04/01/2001 - "After hysterectomy, erythrocytosis rapidly disappeared. "
08/01/2009 - "The polycythemia improved after a hysterectomy which was performed after pulmonary embolectomy."
09/01/2005 - "A voluminous, retroperitoneally located and focally degenerated myoma was associated with severe secondary erythrocytosis (haematocrit: 65.5%) which resolved after hysterectomy. "